Complementary mAb Polishing Solutions for Viral Clearance and Aggregate Removal - Register Now!

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Eluemuno R. Blyden, PhD

Eluemuno R. Blyden, PhD, is the founder and CEO of AfriVax, Inc.

Articles by Eluemuno R. Blyden, PhD

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs

ByPeter K. Watler, PhD,Eluemuno R. Blyden, PhD

January 2nd 2010

Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.

Latest Updated Articles

New Approaches to Improved Vaccine Manufacturing in Embryonated Eggs
January 2nd 2010